|Publication number||US2582242 A|
|Publication date||Jan 15, 1952|
|Filing date||Nov 29, 1947|
|Priority date||Nov 29, 1947|
|Publication number||US 2582242 A, US 2582242A, US-A-2582242, US2582242 A, US2582242A|
|Inventors||Joseph Eberl James|
|Original Assignee||Johnson & Johnson|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (6), Referenced by (19), Classifications (16)|
|External Links: USPTO, USPTO Assignment, Espacenet|
Jan. 15, 1952 J. J. EBERL 2,582,242
CAST FOR ORTHOPEDIC USE Filed Nov. 29, 1947 7702 Una/405E INVENTOR Jwis J 555:4. w/fwioml...
ATTORN EY Patented Jan. 15, 1952 "Ty UNITED" STATES TEN OFFICE "James Joseph Eberl, Piscataway Township, Middlcsex County, N. J., assignor to Johnson & Johnson, a corporation of New Jersey I Application November 29, 1947, Serial No. 788,970
6 Claims. (Cl-112M90 This invention relates to'improved'resin casts;
for orthopedic use and to a process of forming,
the sameand is concerned particularly with casts that are applied from solvent In the past, orthopedic casts were usually based on plaster of Paris which was mixed with water in the form of a heavy paste, applied to a body member and allowed to set, but more recentlya type of bandage has become available wherein a porous web, e. g. crinoline, impregnated with particles of plaster of Paris, is dipped in water for I a few seconds, then wrapped around the body member and allowed to set. Although plaster of Paris bandages are used extensively they have certain important disadvantages such as undue weight andhigh bulk, a high degree of X-ray,
opacity, and imporousness The heavy weight and high bulk of plaster of Paris bandages are disadvantages in casts that are worn by ambu-latory patients, the X-ray opacity prevents ob servation by the physician of callus formation-'- and the imporousness of plaster of Paris casts'j prevents "breathing of the wound or elimination of perspiration and is accordingly responsible for-some of the disagreeable odor that is so often associated with casts that have been worn for long periods of time. Moreover, plaster of Paris does not reach its maximum strength dur-, ing its setting process until one or two days after application and the amount of heat that is given off by thecast during its initial setting make the cast uncomfortable to the patient. I In view of the above-mentioned disadvantages of plaster of Paris casts, bandages based on synthetic or natural resins-have been under development for some time. Their use requires application by wetting of the bandage with solvent, bandaging of the patient, and evaporation of thesolvent as the cast dries out and gains its strength. In the past development of this type of cast, the resins used and the type of cast,
desired necessitated the use of highly toxicor inflammable organic solvents. To many patients and physicians the disadvantages inherent in the use of these solvents outweighed the advantages to be gained by using casts based on materials other than plaster of Paris. In one case, death of a patient was reportedly due to the action or the solvent used mapplication of the cast. Prior to the invention, surgical casts based on resins. or polymers that would not require use of toxic or inflammable solvents were not used.
This invention provides a means of applyingv bandages comprising high polymers wherein there are used solvents that aresubstantlall tree of toxicity and is based uponthe discovery that chlorofluoroparafiins that are liquid at normal room temperatures and that boil at temperatures between 35 and 85* C. in admixture with mutual solvents for ethyl celulose and chlorofluoroparaifins', form satisfactory solvents for ethyl cellu lose.
Other objects andadvantages of the invention will be apparent from the following description of practical embodiments thereof, furnished by way of example only and not in' order to limit the invention, particularly when considered in connection with the drawing wherein:
Fig. 1. is a view in perspective of a resin cast iii-accordance with the invention made from an orthopedic bandage as described herein;
Fig. 2 is a view in perspective of a roll of ortho pedic bandage made in accordance with their!- vention; a
Fig. 3 is an enlarged plan view sho'winga small part of an orthopedic-bandage made in accordance with the invention.
In carrying the invention into practice, fibrous material not great porosity (e. g. crinoline-of wide mesh) is impregnated with ethyl cellulose l3 so as to provide a bandage composed of a major proportion, by weight, of ethyl cellulose. l'he bandage is activated by wetting with anon toxic, non-irritant solvent mixture therefor comprising a major proportion by weight of a liquid chlorofluoroparafiin and a minor proportionof a mutual solvent for ethyl cellulose and chloro- I'luoroparaflin. At least 3% mutual solvent, based on the. totalweight of the solvent mixture, is necessary to provide sufficient solubilityfor the ethyl cellulose in the solvent. The wetted bandage is applied by wrapping it around'the bcdy member and on evaporation of the solvent a rigid, well-laminated cast'results. "This cast is of light weight and low bulk and exceeds in strength a cast of comparable weight made from plaster of Paris. The orthopedic bandage made according to the inventionmay' be coiled into a roll H as illustrated in Fig. 2 and is applied normally to form an orthopedic cast H] as illustrated in, Fig. 1.
While any of the various available typesoi ethyl cellulose may be used in executingthe in vention, ethyl cellulose having an ethoxyl content of between 45 and 50% by weight and a viscosity of 10 centipoises or less in a solution comprising 5% ethyl cellulose in parts by weight oi toluene and 20 parts by weight of ethyl alcohol is preferred because this type of ethyl cellulose is most readily wetted by the solvent and requires The fibrous material base ma comprisean of the well-known web-forming fibrous materials such as cotton, rayon, linen, etc. It is'preferable that the fibrous material be in the form of a fairly open woven gauze, of cheese cloth, or of to- 2,582,242 iii materials can be accurately measured and may be placed in a sealed container, as for example a tin can in which they may be stored for use I by the physician.
In order to disclose the nature of the present invention more clearly, a preferred embodiment thereof will now be described in considerable detail; It is to 'beunderstood; however, that this is done merely by way of example and-solely for the purpose of illustrating by means of a specific example the basic principles which are broadly I .applicable to all the embodiments contemplated bythe invention. In other words, the invention is not restricted in any way to the specific exbacco cloth. The ethyl cellulosemay be applied to the web in the form of an emulsion, or ethyl cellulose fibers may be interwoven with the other fibrous material. The mesh of the bandage is adjusted so that substantial strength and'good porosity are obtained. I 1
The principal component of the solvent is a chlorofluoroparaflin preferably one having 5 or less carbon atoms in the'molecule and either in itself having a boiling point in the range of 35-85 C. or, in any case, adapted to provide a mixture having a boiling point within that range when combined with a minor portion of a mutual solvent for both the chlorofluoroparafiin and the ethyl cellulose. Various chlorofiuoroparamns may be combined to produce a solvent composition that complies with the above specification and all such solvent compositions are included in the inventive concept, By way of example only, the following chlorofiuoroparafiins may be utilized: '1-monochloro-2,'2-1difluoroethane, any trichlorotrifiuoroethane, l-monochloro2,2-difluoropropane, 2-monochloro-3,3-difiuciropropane, 1-monochloro-3,3-trifiu0ropropane, 1,2-dichloro- 1,1-difluoropropane, l,1-dichloro-3,3,3-trifluoropropane, 1,2-dichloro-1,1,2-trifiuoropropane, 1,2- dichloro-3,3,3-trifiuoropropane, 1,2dichlor o- 1,l,2,-3,-3,3-hexafluoropropane, 1,1,2-trichloro-1,2- difiuoropropane, 1,1,2-trichloro-l,2,3,3,3-pentafluoropropane, l,l,2,3-tetrachloro-1,3,3-trifluoropropane, 2-monochloro-2-monofluorobutane, 2- monochloro-3,3-difluorobutane, 2-monochloro- 2,3,3-trifluorobutane, and 1,l,1-trichloro-2,2,3',3- tetrafluorobutane. In general, all chlorofiuoroparaffins falling within the specifications given earlier in thisdescriptiom'are satisfactory solvents for ethyl cellulose provided they are used in admixture with minor proportions of lower alcohols, esters, ethers or ketones or other mutual solvents. Among the mutual solvents, use is'made preferably of ethyl alcohol but methyl or propyl .alcohol or butyl alcohol and related alcohols, esters and/or ketones having eight or less carbon atoms in the molecule can be used. The advantage of ethyl alcohol is its relatively low toxicity and the relatively small proportion necessary to effect satisfactory wetting ofethyl cellulose. These two factors combine to provide maximum safety for patient and physician. Examples of esters that work satisfactorily are methyl acetate, ethyl acetate, propyl acetate, butyl acetate, ethyl propionate, butyl propionate; of ethers, ethyl ether and propyl ether; vof ketones, acetone, methyl ethyl ketone, methyl isopropyl ketone, di-isopropyl ketone and mesityl ample hereinafter described.
, I Example An open mesh,g auze-type cotton cloth having from five to twenty openings to the inch in each direction was impregnated with an ethyl cellulose emulsion comprising:
- Parts Ethyl cellulose. 50 Xylene 84 Butanol 14-.
Water 99 Sorbitol mono-oleate wetting agent"; 2 Dioctyl ester of sodium sulfosuccinic acid 1 In preparing the emulsionthe ethyl cellulose was first dissolved in the mixed solvent and the wetting agent then added.- This solution was heated on a steam bath and added under rapid stirring to a hot'aqueous solution of the sulfosuccinate. The emulsion thickened somewhat on cooling and was applied tothe cloth by a spreading action as with a knife spreader. The bandage was then dried in an oven and was found to contain approximately six parts by weight of ethyl cellulose solids and approximately four parts of base 'cloth. I
In use, the bandage was immersed in about 2 times its weight of a solution'of ninety parts of trichlorotrifluoroethane and ten parts of ethyl alcohol. The bandage was then wound around a body member and allowed to set, preferably by directing thereon a .warm air blower. across the surface thereof. The bandage hardened substantially in less than one-half hour and was completely dried in about three hours. 1 v While in the above example-the ethyl cellulose was applied in the form of an emulsion, it may be applied with good results by other methods such as by solvent or hot melt coating. The sol: vent mixture used may be composed of any chlorofiuoroparaflin, and particularly of any of those listed earlierin this specification, and may comprise. any lower alcohol, ester or ketone as above defined provided the, boilingpoint of the resulting solvent mixture is in the range of 35-85 0. 3-15 of the mutual solvent andthe remainder chlorofluoroparafiin are preferred in the solvent composition. The casts may be canned. in the solvent or stored separately from the solvent and wetted thereby immediately prior to application. In the first few minutes of drying, plaster casts have greater strength than comparable resin'casts of the type disclosed in the invention, but as drying proceeds the resin casts of r the invention gain strength more rapidly than plaster casts and exceed the latter materially in strength. Tests indicate that after about 3 /2 hours of drying time, casts prepared. according to the invention are highly superior in strength to plaster of Pariscasts of the same weight. Resin casts having three to four times the strength of comparable plaster casts were obtained in accordance with this invention. Much lighter casts attain strength equal to that of the heavier plaster casts. Moreover, the cast of the present invention is not only lighter in weight but also highly permeable to air and its use permits ready escape of perspiration from the body member in the cast.
All embodiments within the scope of this specification and/or the appended claims are comprehended in the invention. Many modifications may be made without departing from the spirit and scope of the invention. All variations and modifications are to be understood as included within the scope of the following claims.
The claims are:
1.- The process of applying to a body an orthopedic cast characterized by having a base comprising a porous fabric impregnated with ethyl cellulose, the steps of activating said ethyl cellulose in the fabric by wetting with a solvent composition boiling in the range of 35-85 C. and comprising a major proportion by weight of a chlorofiuoroparafiin and a minor proportion, less than fifteen per cent by weight, of a mutual solvent for said chlorofluoroparaffin and said ethyl cellulose and selected from the group consisting of the lower alcohols, esters, ethers, and ketones having eight or less carbon atoms per molecule, and applying said impregnated and activated fabric to a body, permitting the solvent composition to evaporate.
2. The process of applying to a body an orthopedic cast characterized by having a base comprising a light weight porous fabric having from 5 to 20 strands to the inch in each direction impregnated with ethyl cellulose to the extent of 50-75 per cent by weight of the finished product, the steps of activating said ethyl cellulose in the fabric by wetting using a solvent composition boiling in the range of 35-85 C., and comprising a major proportion of trichlorotrifiuoroethane and a minor proportion, less than fifteen per cent by weight, of ethyl alcohol, applying said impregnated and activated fabric to a body and permitting said solvent composition to evaporate from said fabric.
3. The process of applying to a body an orthopedic cast characterized by having a base comprising a light weight porous fabric impregnated with ethyl cellulose, the steps of activating said ethyl cellulose in the fabric by wetting with a solvent composition that is liquid at normal room temperatures, boils in the range of 35-85 0., and comprises a major proportion of chlorofiuoroparafiin and a minor proportion, less than 15 per cent by weight of said solvent composition, of an alcohol solvent for said chlorofluoroparafiln and said ethyl cellulose and applying said impregnated and activated fabric to a body, permitting said solvent composition to evaporate from said fabric.
4. The process of applying to a body an orthopedic cast characterized by having a base comprising a light weight porous fabric having from 5 to 20 strands to the inch in each direction impregnated with ethyl cellulose to the extent of 50-75 per cent by weight of the finished treated fabric, the steps of activating said ethyl cellulose in the fabric by wetting it with a solvent composition that is liquid at normal room temperatures, boils in the range of 35-85 C., and comprises a major proportion by weight of a chlorofluoroparaffin and a minor proportion, less than fifteen per cent by weight, of a mutual solvent for said chlorofluoroparaifin and said ethyl cellulose and selected from the group consisting of the lower alcohols, esters, ethers, and ketones having eight or less carbon atoms per molecule, and applying said impregnated and activated fabric to a body, permitting said solvent composition to evaporate from said fabric.
5. The process of applying to a body an orthopedic cast characterized by having a base comprising a light weight porous fabric impregnated to the extent of 50-75 per cent by weight of the finished treated fabric with ethyl cellulose having an ethoxyl content between 45 and 50 per cent and a viscosity of not more than 10 centipoises when in solution comprising 5 per cent ethyl cellulose in parts by weight of toluene and 20 parts by weight of ethyl alcohol, the steps of activating said ethyl cellulose in the fabric by wetting it with a solvent composition comprising a major proportion of trichlorotrifluoroethane and a minor proportion, 3-15 per cent of the weight of said solvent composition, of ethyl alcohol, applying said impregnated and activated fabric to a body and permitting said solvent composition to evaporate from said fabric.
6. In the process of applying to a body an orthopedic cast characterized by having a base comprising a light weight porous fabric impregnated with ethyl cellulose, the step of activating said ethyl cellulose in the fabric by wetting with a solvent composition boiling in the range of 35-85 C. and comprising a major proportion by weight of a chlorofiuoroparaflin and a minor proportion, less than'fifteen per cent by weight, of a mutual solvent from said chlorofiuoroparafiin and said ethyl cellulose and selected from the group consisting of the lower alcohols, esters, ethers, and ketones having eight or :less carbon atoms per molecule.
JAlVIES JOSEPH EBERL.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 2,077,874 Brower Apr. 20, 1937 2,218,844 Lovell Oct. 22, 1940 2,254,469 Bjorksten Sept. 2, 1941 2,292,531 Lovell Aug. 11, 1942 2,373,802 Anderson Apr. 17, 1945 2,381,753 Irion Aug. 7, 1945
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2077874 *||Sep 7, 1934||Apr 20, 1937||Ditto Inc||Solvent|
|US2218844 *||May 24, 1938||Oct 22, 1940||Castex Lab Inc||Splint-forming material|
|US2254469 *||Dec 5, 1938||Sep 2, 1941||Ditto Inc||Nonflammable solvent|
|US2292531 *||Oct 2, 1940||Aug 11, 1942||Castex Lab Inc||Cast-forming material|
|US2373802 *||Jul 6, 1942||Apr 17, 1945||Roger Anderson||Surgical cast, cast material, and method|
|US2381753 *||Jan 3, 1941||Aug 7, 1945||Gen Printing Ink Corp||Printing ink|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US2683093 *||Nov 28, 1951||Jul 6, 1954||Johnson & Johnson||Solvent composition|
|US2853067 *||Feb 26, 1957||Sep 23, 1958||Feather Cast Corp||Method and apparatus for applying an orthopedic cast or the like|
|US2969791 *||Apr 30, 1957||Jan 31, 1961||Bofors Ab||Rigid supporting dressing|
|US4411262 *||Dec 31, 1981||Oct 25, 1983||Bayer Aktiengesellschaft||Constructional material|
|US5316690 *||Aug 16, 1991||May 31, 1994||Allied Signal Inc.||Hydrochlorofluorocarbons having OH rate constants which do not contribute substantially to ozone depletion and global warming|
|US5320683 *||Sep 4, 1992||Jun 14, 1994||Asahi Glass Company Ltd.||Azeotropic or azeotropic-like composition of hydrochlorofluoropropane|
|US5705716 *||Jun 6, 1995||Jan 6, 1998||Alliedsignal Inc.||Hydrochlorofluorocarbons having OH rate constants which do not contribute substantially to ozone depletion and global warming|
|US6974431 *||Apr 24, 2003||Dec 13, 2005||Medefficiency, Inc.||Apparatus and method for applying a total contact cast|
|US7758529||Aug 9, 2007||Jul 20, 2010||Medefficiency, Inc.||Systems and methods for improved off-weighting|
|US9192504 *||Apr 17, 2013||Nov 24, 2015||Bsn Medical, Inc.||Total contact cast|
|US9226843||Jan 18, 2012||Jan 5, 2016||Medefficiency, Inc.||Systems and methods for limb support|
|US9433535 *||Apr 14, 2011||Sep 6, 2016||Michael G Crago||Modality and system for casting diabetic and neuropathic plantar foot ulcerations and treating defects that limit range of motion|
|US9597218||Nov 24, 2015||Mar 21, 2017||Medefficiency, Inc.||Systems and methods for limb support|
|US9610186||Apr 22, 2016||Apr 4, 2017||Medefficiency, Inc.||Systems and methods for limb support|
|US20040215120 *||Apr 24, 2003||Oct 28, 2004||Jensen Jeffrey L.||Apparatus and method for applying a total contact cast|
|US20060282031 *||Jan 24, 2006||Dec 14, 2006||Gleiber Michael A||Scented orthopedic device|
|US20080039758 *||Aug 9, 2007||Feb 14, 2008||Medefficiency, Inc.||Systems and methods for improved off-weighting|
|US20120265113 *||Apr 14, 2011||Oct 18, 2012||Crago Michael G||Modlity and system for casting diabetic and neuropathic plantar foot ulcerations and treating defects that limit range of motion.|
|US20140316316 *||Apr 17, 2013||Oct 23, 2014||Bsn Medical, Inc.||Total contact cast|
|U.S. Classification||602/8, 106/162.8, 106/311, 252/364, 106/188.1, 106/193.1, 106/194.3, 106/195.1, 106/192.1|
|International Classification||A61F13/04, A61L15/07, A61L15/00|
|Cooperative Classification||A61L15/07, A61F13/04|
|European Classification||A61L15/07, A61F13/04|